UBS Group
MDRX

UBS Group’s Veradigm Inc. Common Stock MDRX Stock Holding History

UBS Group’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,460
Closed -$445K – 10350
2023
Q4 		$445K Buy
42,460
+39,643
+1,407% +$486K ﹤0.01% 5189
2023
Q3 		$37K Buy
2,817
+634
+29% +$8.31K ﹤0.01% 6479
2023
Q2 		$27.5K Sell
2,183
-11,194
-84% -$136K ﹤0.01% 6750
2023
Q1 		$175K Sell
13,377
-79,976
-86% -$1.3M ﹤0.01% 5495
2022
Q4 		$1.65M Buy
93,353
+80,434
+623% +$1.35M ﹤0.01% 3586
2022
Q3 		$196K Sell
12,919
-44,536
-78% -$720K ﹤0.01% 5101
2022
Q2 		$852K Sell
57,455
-5,508
-9% -$103K ﹤0.01% 3854
2022
Q1 		$1.42M Buy
62,963
+30,497
+94% +$618K ﹤0.01% 3764
2021
Q4 		$599K Sell
32,466
-26,925
-45% -$428K ﹤0.01% 4828
2021
Q3 		$795K Sell
59,391
-16,263
-21% -$263K ﹤0.01% 4376
2021
Q2 		$1.4M Buy
75,654
+31,856
+73% +$536K ﹤0.01% 3891
2021
Q1 		$658K Sell
43,798
-6,041
-12% -$96.7K ﹤0.01% 4649
2020
Q4 		$719K Sell
49,839
-135,917
-73% -$1.65M ﹤0.01% 4287
2020
Q3 		$1.51M Buy
185,756
+150,302
+424% +$1.23M ﹤0.01% 3319
2020
Q2 		$240K Sell
35,454
-19,114
-35% -$124K ﹤0.01% 4669
2020
Q1 		$384K Sell
54,568
-163,150
-75% -$1.32M ﹤0.01% 4196
2019
Q4 		$2.14M Sell
217,718
-5,626
-3% -$59.2K ﹤0.01% 3486
2019
Q3 		$2.45M Buy
223,344
+107,734
+93% +$1.11M ﹤0.01% 3107
2019
Q2 		$1.34M Sell
115,610
-7,386
-6% -$75.1K ﹤0.01% 3495
2019
Q1 		$1.17M Buy
122,996
+10,529
+9% +$116K ﹤0.01% 3450
2018
Q4 		$1.08M Sell
112,467
-314,350
-74% -$3.51M ﹤0.01% 3605
2018
Q3 		$6.08M Sell
426,817
-203,875
-32% -$2.77M ﹤0.01% 2185
2018
Q2 		$7.57M Sell
630,692
-264,167
-30% -$3.26M ﹤0.01% 1966
2018
Q1 		$11.1M Buy
894,859
+787,681
+735% +$11.2M ﹤0.01% 1599
2017
Q4 		$1.56M Sell
107,178
-12,141
-10% -$169K ﹤0.01% 3407
2017
Q3 		$1.7M Sell
119,319
-691,473
-85% -$8.95M ﹤0.01% 3269
2017
Q2 		$10.3M Buy
810,792
+440,402
+119% +$5.35M 0.01% 1510
2017
Q1 		$4.7M Buy
370,390
+213,856
+137% +$2.54M ﹤0.01% 2131
2016
Q4 		$1.6M Sell
156,534
-63,037
-29% -$719K ﹤0.01% 3112
2016
Q3 		$2.89M Sell
219,571
-13,087
-6% -$175K ﹤0.01% 2511
2016
Q2 		$2.95M Sell
232,658
-131,643
-36% -$1.75M ﹤0.01% 2441
2016
Q1 		$4.81M Buy
364,301
+193,582
+113% +$2.54M ﹤0.01% 1903
2015
Q4 		$2.63M Buy
170,719
+36,299
+27% +$521K ﹤0.01% 2549
2015
Q3 		$1.67M Buy
134,420
+10,848
+9% +$149K ﹤0.01% 2907
2015
Q2 		$1.69M Buy
123,572
+16,463
+15% +$222K ﹤0.01% 3134
2015
Q1 		$1.28M Sell
107,109
-856,353
-89% -$10.5M ﹤0.01% 3347
2014
Q4 		$12.3M Buy
+963,462
New +$12.3M 0.01% 1349

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's MDRX Position: Q1 2024 in Review

UBS Group sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 42,460 shares — an estimated $445K sold.

UBS Group first reported a position in MDRX in Q4 2014 and held it in 37 quarters. The position peaked at $12.3M in Q4 2014. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • UBS Group reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 42,460 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $445K.
  • UBS Group first reported a position in Veradigm Inc. Common Stock in Q4 2014 and held it in 37 quarters.
  • UBS Group's Veradigm Inc. Common Stock position peaked at $12.3M in Q4 2014.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.